CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-10 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +958 | 958 | ||
| 2018-12-10 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +4,060 | 4,060 | ||
| 2018-12-10 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +30,450 | 30,450 | ||
| 2018-12-10 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +102,200 | 102,200 | ||
| 2018-12-10 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +60,900 | 60,900 | ||
| 2018-12-10 | Freedman Lori VP and General Counsel | Grant or award · Stock Option (Right to Buy) | +40,600 | 40,600 | ||
| 2018-12-10 | Cunningham Timothy M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +559,620 | 559,620 | ||
| 2018-12-10 | Bilbo Patrick Chief Operating Officer | Grant or award | +121,800 | 121,800 | ||
| 2018-12-10 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +30,450 | 30,450 | ||
| 2018-12-10 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +152,250 | 152,250 | ||
| 2018-12-10 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +142,100 | 142,100 | ||
| 2018-12-10 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +101,500 | 101,500 | ||
| 2018-12-10 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +397,900 | 397,900 | ||
| 2018-12-10 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +704,410 | 704,410 | ||
| 2018-12-10 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +664,804 | 664,804 | ||
| 2018-12-10 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +1,637,631 | 1,637,631 | ||
| 2018-12-10 | Avista Acquisition Corp. 10% owner | Other disposition · Class B Ordinary Shares | −3,247,668 | 1,048,691 | ||
| 2018-12-10 | Bjorklund Hakan Director | Returned to the company · Class B Ordinary Shares | −243,896 | 69,571 | ||
| 2018-12-10 | MARKISON BRIAN A Director | Returned to the company · Class B Ordinary Shares | −442,151 | 133,589 | ||
| 2018-12-10 | Harwood Charles C Jr Director | Returned to the company · Class B Ordinary Shares | −243,896 | 69,571 |
Page 30 of 32 · 627 trades